English  |  正體中文  |  简体中文  |  2856565  
???header.visitor??? :  53424126    ???header.onlineuser??? :  631
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yang c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 256-265 of 1273  (128 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-06-27T07:07:45Z Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer Lee J.-H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏 2022-06-27T07:07:45Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:44Z Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:44Z Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T.
臺大學術典藏 2022-06-27T07:07:42Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; CHONG-JEN YU; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:36Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:35Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:35Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:31Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:28Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.

Showing items 256-265 of 1273  (128 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page